Literature DB >> 10962234

Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.

S Santoyo1, P Ygartua.   

Abstract

The enhancing effect of several fatty acids from different subclasses: saturated (lauric acid), mono-unsaturated (oleic acid) and poly-unsaturated (linoleic and linolenic acids) in the percutaneous absorption of piroxicam was investigated. These fatty acids were applied on the skin membrane in three different ways: included in the vehicle, as a pretreatment or both. An increase in piroxicam flux value was found for lauric and oleic acids in the following order: skin pretreatment with 5% fatty acids followed by application of gels containing 5% fatty acids>skin pretreatment with 5% fatty acids followed application of control gel>gel containing 5% fatty acids without skin pretreatment. For linoleic and linolenic acids, the piroxicam flux in the two pretreatment experiments was almost the same, although higher than when fatty acids were included in the formulation. Skin pretreatment with 5% linolenic acid in propylene glycol followed by application of control gel or a gel containing 5% linolenic acid, showed the highest enhancing capacity. After skin pretreatment with fatty acids, the lag time values decreased nearly three times compared to those obtained when the same fatty acids were included in the formulation. The amount of piroxicam retained in the skin after pretreatment with fatty acids was found to be very similar for all fatty acids and 3-fold higher than in the experiments without skin pretreatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962234     DOI: 10.1016/s0939-6411(00)00097-7

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  12 in total

1.  Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.

Authors:  Adrian P Funke; Roman Schiller; Hans W Motzkus; Clemens Günther; Rainer H Müller; Ralph Lipp
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.

Authors:  Hyun-Ah Cheong; Hoo-Kyun Choi
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

3.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

4.  Exploring unsaturated fatty acid cholesteryl esters as transdermal permeation enhancers.

Authors:  Sanjeev Rambharose; Rahul S Kalhapure; Mahantesh Jadhav; Thirumala Govender
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

5.  Topical piroxicam in vitro release and in vivo anti-inflammatory and analgesic effects from palm oil esters-based nanocream.

Authors:  Muthanna F Abdulkarim; Ghassan Z Abdullah; Mallikarjun Chitneni; Ibrahim M Salman; Omar Z Ameer; Mun F Yam; Elrashid S Mahdi; Munavvar A Sattar; Mahiran Basri; Azmin M Noor
Journal:  Int J Nanomedicine       Date:  2010-11-04

6.  Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules.

Authors:  Grace Tan; Peng Xu; Louise B Lawson; Jibao He; Lucia C Freytag; John D Clements; Vijay T John
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

7.  Evaluation of skin absorption of the Citrullus colocynthis in treatment of type II diabetic patients.

Authors:  Akram Ahangarpour; Rafie Belali; Fatemeh Bineshfar; Shokoh Javadzadeh; Leila Yazdanpanah
Journal:  J Diabetes Metab Disord       Date:  2020-03-07

8.  Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.

Authors:  Sílvia S Guterres; Marta P Alves; Adriana R Pohlmann
Journal:  Drug Target Insights       Date:  2007-07-11

9.  Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride.

Authors:  D Prasanthi; P K Lakshmi
Journal:  ISRN Pharm       Date:  2012-12-20

10.  Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.

Authors:  Bhavna Dhawan; Geeta Aggarwal; Sl Harikumar
Journal:  Int J Pharm Investig       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.